Here are relevant reports on : oral-drug-delivery-market
-
Top 10 Drug Delivery Technologies Market (Topical, Oral Time Release/Sustained Release, Targeted Delivery, Encapsulation, Aerosol/Inhalation, Transdermal, Implants, Injectable, Liposomal, Pegylation) - Global Trends, Challenges & Forecasts up till 2015
This report provides industry analysis, competitive landscape and in-depth market segmentation for all the top 10 drug delivery technologies. It provides market data for the oral delivery system, which still dominates the drug delivery market. In addition, the report also analyzes the market data on emerging drug delivery technologies like needleless injectables, PEGylation technologies and microelectromechanical devices.
- Published: February 2011
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1 million in 2023, stood at US$1,949.4 million in 2024 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2029, culminating in a forecasted valuation of US$2,546.0 million by the end of the period. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Pharmaceutical Drug Delivery Market by Route of Administration (Injectable [Syringe, Auto injector], Oral [Tablet, Capsule, Syrup], Topical, Nasal, Ocular, Rectal), Application (Cancer, Diabetes, CVD, Ophthalmic) - Forecast to 2031
The Middle East & Africa Pharmaceutical Drug Delivery market, valued at USD 37.39 billion in 2025, stood at USD 38.20 billion in 2026 and is projected to advance at a resilient CAGR of 4.8% from 2026 to 2031, culminating in a forecasted valuation of USD 48.22 billion by the end of the period. The Middle East & Africa pharmaceutical drug delivery market is expanding steadily due to the modernization of healthcare infrastructure and the growing adoption of patient-friendly treatment modalities.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
US Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injectable, Topical (Cream, Transdermal, Suppositories), Ocular, Nasal, Transmucosal, Implantable], Application (Cancer, Diabetes), Care Setting - Forecast to 2031
The US pharmaceutical drug delivery market, valued at US$0.91 billion in 2025, stood at US$0.94 billion in 2026 and is projected to advance at a resilient CAGR of 5.8% from 2026 to 2031, culminating in a forecasted valuation of US$1.24 billion by the end of the period. The market growth trend is fueled by several factors. One of the primary drivers is the quick and extensive rise of biologics and biosimilars, necessitating advanced injectable and large-volume delivery systems.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Drug Delivery Market by Route of Administration (Oral, Injectors (Auto Injectors), Implantable, Transmucosal, Nasal, Syringes), Application (Cancer, Diabetes), Care Setting (Hospital, Home Care) - Forecast to 2031
The Asia Pacific pharmaceutical drug delivery market, valued at US$457.9 million in 2025, stood at US$479.7 million in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of US$687.9 million by the end of the period. The market growth for drug delivery in the APAC region is steadily expanding due to an increase in disease prevalence, an increase in the adoption rate of biologics, advancements in technologies, and an increase in regional production.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
North America Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Prefilled Syringes), Packaging Type (Primary, Secondary), Drug Delivery (Oral, Injectables), Raw Material (Plastics, Paper & Paperboard), and Country - Forecast to 2030
The North America pharmaceutical packaging market is projected to grow from USD 57.26 billion in 2025 to USD 114.33 billion by 2030, at a CAGR of 14.8% during the forecast period. The key players in the pharmaceutical packaging market in North America include AptarGroup, Inc. (US), Becton Dickinson & Co. (BD) (US), West Pharmaceutical Services, Inc. (US), WestRock (US), Catalent, Inc. (US), Sealed Air Corporation (US), CCL Industries (US), and Owens-Illinois, Inc. (O-I Glass) (US).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Europe Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injector, Topical (Cream, Transdermal Patch), Transmucosal, Nasal], Application [Cancer, Diabetes], Care Setting [Hospital, Homecare]- Forecast to 2031
The Europe Pharmaceutical drug delivery market, valued at USD501.62 billion in 2025, stood at USD519.62 billion in 2026 and is projected to advance at a resilient CAGR of 6.2% from 2026 to 2031, culminating in a forecasted valuation of USD703.19 billion by the end of the period. The market growth is driven by rising use of biologics and biosimilars, an increasing prevalence of chronic diseases, and growing acceptance of innovative drug delivery devices, including auto-injectors, prefilled syringes, and inhalation systems.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery (Oral, Injectables, Topical), Packaging Type, Raw Material, And Country - Forecast to 2030
The Asia Pacific pharmaceutical packaging market is projected to grow from USD 52.15 billion in 2025 to USD 119.48 billion by 2030, at a CAGR of 18% during the forecast period. The key players in the Asia Pacific pharmaceutical packaging market include Amcor plc (Switzerland), Gerresheimer AG (Germany), SCHOTT AG (Germany), Becton Dickinson & Co (US), WestRock Company (Ireland), AptarGroup, Inc (US), West Pharmaceutical Services, Inc (US), Parekhplast India Ltd. (India), Nipro Corporation (Japan), and SGD Pharma (France).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Latin America Pharmaceutical Drug Delivery Market by Route of Administration [Injectable (Prefilled Syringe, Self Injection Devices), Oral (Tablet, Capsule, Liquid), Topical, Buccal, Nasal, Rectal], Application (Cancer, Diabetes, CVD) - Forecast to 2031
The latin america pharmaceutical drug delivery market, valued at USD 72.7BN in 2025, stood at USD 75.3BN in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 102.1BN by the end of the period. Some of the prominent players in the Latin America pharmaceutical drug delivery market include Pfizer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Sanofi (France), AstraZeneca (UK), GSK Plc (UK), Eurofarma (Brazil), Bayer AG (Germany), EMS (Brazil), BD (US), Teva Pharmaceutical Industries Ltd. (Israel), and Hypera Pharma (Brazil).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Drug Screening Market by Offering [On-site Testing, Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)], Sample (Blood, Urine, Hair), Drug (Cannabis, Alcohol), End User (Workplace, Law, Hospitals) - Global Forecast to 2030
The global drug screening market, valued at US$8.92 billion in 2024, stood at US$10.36 billion in 2025 and is projected to advance at a resilient CAGR of 15.5% from 2025 to 2030, culminating in a forecasted valuation of US$21.29 billion by the end of the period. The market for drug screening is being fueled by growing workplace and clinical testing programs, an increased need for opioid/polysubstance monitoring, and an increased use of rapid point-of-care technologies and advanced confirmatory testing (LC MS/MS) systems.
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
